Age at Onset of Metabolic Syndrome Among Women With and Without Polycystic Ovary Syndrome-Like Status.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 29 06 2018
accepted: 28 11 2018
pubmed: 6 12 2018
medline: 28 2 2020
entrez: 6 12 2018
Statut: ppublish

Résumé

Women with polycystic ovary syndrome (PCOS) have a higher prevalence of metabolic syndrome (MetS), but whether they develop MetS earlier than women without PCOS is unknown. Understanding the impact of PCOS on the timing of MetS onset is important for screening and clinical care in this population. Women with PCOS-like status (PCOSp) were identified from participants of the Michigan Bone Health and Metabolism Study based upon history of irregular menstrual cycles, high free-androgen index, and high levels of antimüllerian hormone. MetS was defined according to the Adult Treatment Panel III criteria. Age at MetS onset was compared between women with and without PCOSp using an accelerated failure time model adjusted for baseline education, lifestyle factors, and midlife body weight. Among the 496 women in the analysis, 11.7% (n = 58) were determined to have PCOSp. Over a mean follow-up of 11 years, 20 women with PCOSp and 136 women without PCOSp developed MetS. After adjusting for smoking, education, and physical activity, women with PCOSp developed MetS at an age 14.4% (95% CI -22.7, -5.2) younger than women without PCOSp. The magnitude of the association was attenuated to 5.4% in models additionally adjusted for body mass index (95% CI -12.4, 2.1). Because a typical study participant without PCOSp developed MetS at 51.5 years old, 5.4% translates to almost 3 years earlier onset of MetS for a comparable woman with PCOSp. Women with PCOSp develop MetS at a younger age. Earlier screening for MetS in women with PCOS may be warranted.

Identifiants

pubmed: 30517661
pii: 5224748
doi: 10.1210/jc.2018-01428
pmc: PMC6435100
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1429-1439

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR051384
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008455
Pays : United States

Informations de copyright

Copyright © 2019 Endocrine Society.

Références

J Sports Med Phys Fitness. 1965 Sep;5(3):127-31
pubmed: 5850778
Obes Rev. 2015 Jan;16(1):1-12
pubmed: 25407540
J Clin Endocrinol Metab. 2008 Sep;93(9):3478-83
pubmed: 18593767
J Clin Endocrinol Metab. 2012 Jun;97(6):E868-77
pubmed: 22466350
Am J Epidemiol. 1999 Jan 1;149(1):47-54
pubmed: 9883793
Hum Reprod Update. 2010 Jul-Aug;16(4):347-63
pubmed: 20159883
Clin Endocrinol (Oxf). 2011 Nov;75(5):692-7
pubmed: 21592169
Am J Epidemiol. 2001 Feb 1;153(3):256-64
pubmed: 11157413
Endocr Rev. 2016 Oct;37(5):467-520
pubmed: 27459230
Fertil Steril. 2014 Nov;102(5):1444-1451.e3
pubmed: 25239303
Clin Endocrinol (Oxf). 2011 Jan;74(1):89-96
pubmed: 21044112
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
BMC Med. 2016 Oct 3;14(1):151
pubmed: 27716302
Obstet Gynecol. 2005 Jul;106(1):131-7
pubmed: 15994628
Hum Reprod Update. 2014 May-Jun;20(3):334-52
pubmed: 24345633
Curr Diab Rep. 2006 Feb;6(1):77-83
pubmed: 16522285
J Clin Endocrinol Metab. 2014 Jun;99(6):2120-7
pubmed: 24517154
Hum Reprod. 2002 Sep;17(9):2219-27
pubmed: 12202405
Med Sci Sports Exerc. 1993 Jan;25(1):71-80
pubmed: 8292105
Fertil Steril. 2017 Mar;107(3):788-795.e2
pubmed: 28089571
Clin Endocrinol (Oxf). 2018 Feb;88(2):169-184
pubmed: 28930378
Endocr Pract. 2015 Dec;21(12):1415-26
pubmed: 26642102
Fertil Steril. 2004 Jan;81(1):19-25
pubmed: 14711538
J Clin Endocrinol Metab. 2004 Jun;89(6):2590-4
pubmed: 15181028
Metabolism. 2003 Jul;52(7):908-15
pubmed: 12870169
Fertil Steril. 2016 Nov;106(6):1510-1520.e2
pubmed: 27530062
Fertil Steril. 2014 Feb;101(2):530-5
pubmed: 24382375
Hum Reprod. 2010 Feb;25(2):544-51
pubmed: 19910321
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
J Clin Endocrinol Metab. 2013 Aug;98(8):3332-40
pubmed: 23775353
Intern Med J. 2015 Dec;45(12):1247-54
pubmed: 26387977
Hum Reprod. 2016 Dec;31(12):2841-2855
pubmed: 27664216
J Clin Endocrinol Metab. 2005 Apr;90(4):1929-35
pubmed: 15623819
Hum Reprod. 2009 Sep;24(9):2276-85
pubmed: 19520711

Auteurs

Qing Peng (Q)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.

Carrie A Karvonen-Gutierrez (CA)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.

John F Randolph (JF)

2Division of Reproductive Endocrinology and Infertility, University of Michigan Health System, Ann Arbor, Michigan.

Bin Nan (B)

3Department of Statistics, University of California at Irvine, Irvine, California.

Daniel McConnell (D)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.

Siobán D Harlow (SD)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH